Filters
reset allOther countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Invitae Expanded Renal Disease Panel Invitae United States | 693 | 388 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Invitae Disorders of Sex Development Panel Invitae United States | 88 | 53 |
|
Invitae United States | 57 | 27 |
|
Invitae United States | 409 | 164 |
|
Invitae United States | 160 | 62 |
|
Invitae 78 Gene Actionable Disorders Panel Invitae United States | 220 | 75 |
|
Invitae Inherited Retinal Disorders Panel Invitae United States | 486 | 293 |
|
Genetiks Genetic Diagnosis Center Genetic Diseases Evaluation Center Turkey | 1 | 1 |
|
Aniridia (PAX6 Single Gene Test) Fulgent Genetics United States | 8 | 1 |
|
Congenital Cataracts NGS Panel Fulgent Genetics United States | 106 | 56 |
|
Comprehensive Glomerular Proteinuria NGS Panel Fulgent Genetics United States | 182 | 76 |
|
Fulgent Genetics United States | 47 | 24 |
|
Fulgent Genetics United States | 49 | 15 |
|
Neuro-Ophthalmic Disorders NGS Panel Fulgent Genetics United States | 52 | 26 |
|
Denys-Drash Syndrome (WT1 Single Gene Test) Fulgent Genetics United States | 8 | 1 |
|
Frasier Syndrome (WT1 Single Gene Test) Fulgent Genetics United States | 8 | 1 |
|
Retinopathy and Optic Atrophy NGS Panel Fulgent Genetics United States | 563 | 241 |
|
Fulgent Genetics United States | 505 | 132 |
|
ACMG Secondary Findings (Medically Actionable Genes, Including Cardio and Cancer) NGS Panel Fulgent Genetics United States | 177 | 59 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.